Find Comparable Stocks for Biogen Inc.
Biogen Inc.
BIIB - NMSLife Sciences
Biological Products, (no Disgnostic Substances)
Country
USA
Market Cap
$21.6B
Dividend Yield
N/A
Beta
0.01 (No Correlation)
Trading Volume
1.1M (Moderate)
Momentum
Very Weak
Weak
Very Strong
Value vs. Growth
Deep Value
Fair Value
Rapid Growth
Quality
Poor
Average
Excellent
Size
Micro
Large
Mega Cap
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Valuation
Financials
Momentum
Analyst Ratings
Trailing P/E
12.86
Forward P/E
9.07
PEG Ratio
6.24
Price/Book
1.25
EV/EBITDA
8.88
EV/Revenue
2.60
Income Statement
Revenue (TTM)
$9.7B
Gross Profit (TTM)
$7.4B
EBITDA
$3.0B
Financial Ratios
Profit Margin
17%
Operating Margin (TTM)
22%
Gross Profit Margin
76%
EBITDA Margin
31%
ROE (TTM)
10%
ROA (TTM)
5%
Growth
Quarterly Revenue Growth (YoY)
3%
Quarterly Earnings Growth (YoY)
6%
52-Week Range
$128.51
$238.00
50-Day Moving Average
$144.26
Price vs. 50-Day MA
2.16%
200-Day Moving Average
$185.00
Price vs. 200-Day MA
-20.34%
Analyst Ratings Distribution
Median Price Target
$201.18
Price to Target
73%
Toggle between similar stocks
and ETFs for comparison.
Loading comparable stocks ...